OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
LENS58

Lenskart Solutions Ltd

Medical Equipment, Supplies & DistributionVerified

Lenskart Solutions Ltd maintains a debt-to-equity ratio of 0.42, indicating a relatively conservative capital structure. The company's liquidity position is characterized as medium, with a current ratio of 1.94, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's net cash position is negative after subtracting total debt, which raises concerns about its liquidity flexibility. In terms of profitability, Lenskart's return on equity (ROE) is 4.88%, and its return on assets (ROA) is 2.84%. These figures are below the typical thresholds for strong performance in the retail and healthcare equipment sectors, indicating that the company is generating modest returns relative to its equity and asset base. The company's revenue is primarily concentrated in India, with a significant portion derived from its online and physical retail operations. While the input data does not provide a detailed breakdown of geographic exposure, the company's operations are largely domestic, which may expose it to regional economic and regulatory risks. Lenskart's growth trajectory is reflected in its operating cash flow of INR 12.3 billion and free cash flow of INR 5.38 billion. These figures suggest the company is generating positive cash from operations and has the capacity to fund future growth initiatives. However, the capital expenditure of INR 426.7 million indicates ongoing investment in infrastructure and expansion. The company's risk profile includes a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, suggesting potential pressure on liquidity. The dilution risk is low, with no significant dilution potential identified in the basic shares outstanding. Recent events and filings indicate that the company is under analyst scrutiny, with a mean price target of INR 541.73 and a median price target of INR 550.00. The mean recommendation of 1.93 suggests a generally positive outlook, with 6 strong-buy ratings and 5 buy ratings from analysts.

30-day price · LENS-38.45 (-7.0%)
Low$458.75High$557.65Close$510.75As of26 May, 00:00 UTC
Profile
CompanyLenskart Solutions Ltd
TickerLENS.NS
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Lenskart Solutions Ltd operates in the healthcare services and equipment industry, primarily offering eyewear and related products through a combination of online and physical retail channels.

Classification. Lenskart is classified under the Healthcare sector, specifically in the Medical Equipment, Supplies & Distribution industry, with a high confidence level of 0.92 based on verified market data.

Lenskart Solutions Ltd maintains a debt-to-equity ratio of 0.42, indicating a relatively conservative capital structure. The company's liquidity position is characterized as medium, with a current ratio of 1.94, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's net cash position is negative after subtracting total debt, which raises concerns about its liquidity flexibility. In terms of profitability, Lenskart's return on equity (ROE) is 4.88%, and its return on assets (ROA) is 2.84%. These figures are below the typical thresholds for strong performance in the retail and healthcare equipment sectors, indicating that the company is generating modest returns relative to its equity and asset base. The company's revenue is primarily concentrated in India, with a significant portion derived from its online and physical retail operations. While the input data does not provide a detailed breakdown of geographic exposure, the company's operations are largely domestic, which may expose it to regional economic and regulatory risks. Lenskart's growth trajectory is reflected in its operating cash flow of INR 12.3 billion and free cash flow of INR 5.38 billion. These figures suggest the company is generating positive cash from operations and has the capacity to fund future growth initiatives. However, the capital expenditure of INR 426.7 million indicates ongoing investment in infrastructure and expansion. The company's risk profile includes a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, suggesting potential pressure on liquidity. The dilution risk is low, with no significant dilution potential identified in the basic shares outstanding. Recent events and filings indicate that the company is under analyst scrutiny, with a mean price target of INR 541.73 and a median price target of INR 550.00. The mean recommendation of 1.93 suggests a generally positive outlook, with 6 strong-buy ratings and 5 buy ratings from analysts.
Key takeaways
  • Lenskart maintains a conservative capital structure with a debt-to-equity ratio of 0.42.
  • The company's ROE of 4.88% and ROA of 2.84% indicate modest profitability.
  • The company's liquidity position is medium, with a current ratio of 1.94.
  • Analysts have a generally positive outlook, with a mean price target of INR 541.73.
  • The company's growth is supported by positive operating and free cash flows.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$66.53B
Gross profit$44.89B
Operating income$1.88B
Net income$2.97B
R&D
SG&A
D&A
SBC
Operating cash flow$12.31B
CapEx-$4.27B
Free cash flow$5.38B
Total assets$104.71B
Total liabilities$43.72B
Total equity$60.99B
Cash & equivalents$300.9M
Long-term debt$25.72B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$60.99B
Net cash-$25.42B
Current ratio1.9
Debt/Equity0.4
ROA2.8%
ROE4.9%
Cash conversion4.1%
CapEx/Revenue-6.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricLENSActivity
Op margin2.8%3.9% medp25 -31.3% · p75 14.4%below median
Net margin4.5%2.4% medp25 -30.5% · p75 11.1%above median
Gross margin67.5%46.7% medp25 28.2% · p75 63.1%top quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-6.4%-4.8% medp25 -11.6% · p75 -2.4%below median
Debt / equity42.0%17.9% medp25 2.7% · p75 52.2%above median
Observations
IR observations
Mean price target541.73 INR
Median price target550.00 INR
High price target625.00 INR
Low price target389.00 INR
Mean recommendation1.93 (1=strong buy, 5=strong sell)
Strong-buy count6.00
Buy count5.00
Hold count3.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate2.70 INR
Mean revenue estimate87,349,425,930 INR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-22 04:30 UTC#e0e6ed58
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 09:59 UTCJob: 963c7736